Connect with us

Emerging Markets

Bowmo™, Inc. (OTCMKTS: BOMO) AI Driven Staffing Co with Global Ambitions & Powerhouse Management Team

Published

8 months ago

on

Bowmo™, Inc. (OTCMKTS: BOMO) accumulation continues as new investors jump on board looking for the next big OTC runner. The Company recently completed the name and ticker change from CZNI after Bowmo went public via a reverse merger into the Company. Bowmo is an Artificial Intelligence staffing platform and their flagship product; V-RPO is a combination of proprietary AI-based technology for a do-it-yourself sourcing experience, matching candidates to jobs from 200 million potential candidates without having to use keyword searches or Boolean strings that recently expanded into Europe. The Company has been quickly expanding into new international markets by recruiting talented IT professionals in the European Union and internationally. Bowmo biggest business account is Endeavor, one of the largest sports and entertainment companies in the world, whose holdings include the William Morris Agency. Endeavor Group Holdings EDR on NYSE trades at a $6.7 billion market valuation and did $1.4 billion in Q2, 2022 revenues.  

The new owners of BOMO, Michael Lakshin, a business executive and serial entrepreneur who has been involved in multiple IPOs in the U.S. and internationally and Edward Aizman recently recognized as the top 100 Staffing Leader to Watch in 2022 have an ambitious vision to make Bowmo a global AI staffing powerhouse and take it to NASDAQ. To this end they have assembled a powerhouse management team including Mr. Michael R. Neece a business and talent acquisition executive at Fortune 100 companies that has founded 7 technology-enabled SaaS start-ups. Mr. Neece is a TED Talk speaker who’s appeared on or been quoted on NBC, ABC, CBS, Financial Times, Yahoo Finance, Bloomberg, and the Wall Street Journal. Keith Carlson, the Company’s Chief Information Officer is a technology executive that has led projects in the use of AI in complex situations including STEM education and public health in the US and internationally. Jay Cury, the Company Chief People Officer has worked for years in traditional recruiting and talent acquisition and is a technological leader serving to modernize recruiting processes by redesigning talent acquisition to fit business initiatives. As an entrepreneur, he built three profitable start-ups and served in talent acquisition advisory roles for multiple international companies. 

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Bowmo™, Inc. (OTCMKTS: BOMO) is HRTech Made by Recruiters for Recruiters. The bowmo™ V-RPO is a combination of proprietary AI-based technology for a do-it-yourself sourcing experience, matching candidates to jobs from 200 million potential candidates without having to use keyword searches or Boolean strings. The bowmo™ V-RPO automates the process with its AI-based matching engine and then provides industry-superior tools such as video interviewing and cultural and technical assessments so that customers can vet their candidates. With the bowmo™ AI-driven platform at the core performing the matching and sourcing, bowmo™ can reinvent how businesses find talent and provide a quality on-demand experience like no other competitors within this space. By using the bowmo™ AI technology, recruiters will be in complete control of their existing ATS data and will be able to improve precision and timing for talent acquisition, job sourcing, and candidate engagement. 

The Company’s biggest client is Endeavor Group Holdings, Inc. (NYSE: EDR), trading at a $6.7 billion market valuation and reporting $1.4 billion in Q2, 2022 revenues. Endeavor Group is one of the largest sports and entertainment companies in the world, whose holdings include, but are not limited to, The William Morris Agency, the longest-serving talent agency in the world, as well as, IMG and UFC, and more. bowmo™ became one of Endeavor’s trusted HR vendors in September 2021 by providing RaaS and direct-placement services for Endeavor Digital, and then for other companies in the Holding, such as Next College Student Athlete (NCSA), IMG Academy, On Location, Endeavor Streaming, and Endeavor|MainConcept. Most recently, Endeavor entrusted bowmo™’s RaaS and Direct Placement team to find qualified candidates for their mother company, Endeavor Group Holdings, Inc. Over the past year, Endeavor became the largest client of bowmo™, helping the Company to move up in the big-league ranks.

Microcapdaily first reported on CZNI on July 8 when the stock was trading at $0.0005 just as it was taking off towards $0.0018 highs, stating at the time: On May 4, 2022, Cruzani, Inc., Bowmo Merger Sub, Inc., Bowmo, Inc., and the shareholders of Bowmo, Inc. entered into a reverse triangular merger, pursuant to which Bowmo, Inc. was the surviving corporation.  As a result of the merger, registrant acquired from Bowmo the following assets. As consideration for the assets Cruzani issued to Bowmo’s two majority shareholders, Michael Lakshin and Edward Aizman, a total of 1,000,000 shares of its Series G Preferred Stock holding the voting rights to 78% of the total voting equity securities. Mr. Lakshin was issued 448,000 shares and Mr. Aizman was issued 552,000 shares.  As a result of the merger, on May 4, 2022, control of registrant changed from its prior majority shareholder, Conrad R. Huss, to Michael Lakshin and Edward Aizman who now control the voting rights to 78% of the total voting equity securities.  In addition, on May 9, 2022, at a meeting of registrant’s Board of Directors, Mr. Huss appointed Mr. Lakshin and Mr. Aizman as additional directors.  Mr. Lakshin and Mr. Aizman now hold two of the three positions on Bowmo’s Board of Directors. Prior to the merger, Conrad R. Huss was the sole director and officer of registrant.  

  To Find out the inside Scoop on BOMO Subscribe to Microcapdaily.com Right Now by entering your Email in the box below

On October 6 the Company issued a letter to shareholders that stated:  

From “CZNI” to “BOMO” 

After almost three months, FINRA finally (https://www.finra.org/#/) approved the ticker symbol change from “CZNI” to “BOMO,” which went into effect on Monday, September 26, 2022. 

From bowmo 1.0 to bowmo 2.0 

bowmo (@bowmonyc) / TwitterThe global pandemic has inevitably reshaped the hiring process. In the post-COVID-19 world as we move forward, current options for recruiting will change dramatically, with more people looking for work and fewer options for cost-effective recruitment solutions that currently only serve the largest companies. Under this new scenario, the upper-mid and mid-marketplace will be largely underserved. Companies that will be looking to hire are not going to contemplate an outsourced recruiting engagement with high fees or have the deep pockets for a traditional Recruitment Process Outsourcing (RPO) option. They will have to post to job boards and sort through hundreds of applicants—all with a reduced workforce themselves. The bowmo V-RPO platform allows for completely contactless hiring, which enables companies of all sizes to hire amid tightened social distancing rules. Companies are increasingly shifting toward virtual hiring as a necessity to mitigate risks, so bowmo’s ultimate objective is to stay ahead of the competition. 

Today bowmo is focusing on developing strategic partnerships and has entered a revenue-generating phase with a targeted customer pipeline, access to large channels for rapid growth and scale, and a market demand that will require higher service at a reduced price for current market options. In addition, bowmo’s management team has decided to add an integrated Candidate Portal to the bowmo 2.0 application as part of the overall functionality improvement, where job seekers will be able to upload their résumés and will be matched with targeted jobs instantly. 

With the bowmo technology platform at the core performing the matching and sourcing, bowmo can reinvent how businesses find talent and provide a quality on-demand experience, like no other competitors within this space. The bowmo V-RPO can enhance recruiting agencies and midmarket RPOs, generating massive growth and scale. As such, bowmo’s motto is “Innovation Never Stops.” 

Today, we are in the process of developing new and additional features and capabilities that will allow bowmo to take competitive advantage moving forward. In the reporting period, bowmo made substantial progress with the development of the bowmo 2.0 platform. Our software development team in Switzerland, led by one of the best AI architects, Damian Hischier, has reported 30% to 40% completion of new additional features set to bring the bowmo 2.0 platform to the next level: 

  • AI/ML-powered search for more precise candidate/job matching
  • Automated candidate matching based on job skill set
  • Interview Mastery Automation process
  • Interview preparation and coaching
  • RaaS offering—preparing candidates for hiring teams to accelerate hiring
  • Automating repetitive recruiting tasks so users can focus on high-value activities
  • On-demand video-based e-learning for best-practice hiring processes
  • Social media outreach

Following the broadened market reach of bowmo’s largest corporate client, Endeavor Group Holdings, Inc. (NYSE: EDR), bowmo has been engaged to fulfill multiple strategic senior IT positions for the Endeavor Group of Companies in Bulgaria, Lithuania, Estonia, Croatia, Czech Republic, Austria, Finland, Poland, and Germany. In order to speed up the preselection of qualified candidates for the Endeavor Group of Companies in the EU, bowmo’s management decided to outsource professional recruiters based in Ukraine who are more familiar with HR markets in the EU. 

 

For More on BOMO Subscribe Right Now!

Currently trading at a $13 million market valuation BOMO is an SEC filer trading at just $0.0006 with a 52-week high of $0.0018 about 300% above the current pps. The stock has a fast growing and very loyal shareholder base who are accumulating BOMO and are looking for the next big OTC runner here. There is a lot to get excited about here; an AI driven staffing Company with global ambitions that has already got Endeavor, one of the largest sports and entertainment companies in the world with Q2 revenues of $1.4 billion on board as their biggest client. The Company has quickly assembled a powerhouse management team that is rolling up their sleeves and getting to work with big things expected to be happening here. Speculators are looking for a break of $0.0018 and eventually from there, a big move into copperland. We will be updating on BOMO when more details emerge so make sure you are subscribed to Microcapdaily.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: we hold no position in BOMO either long or short and we have not been compensated for this article

Related Topics:
Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Emerging Markets

Aclarion Inc (NASDAQ: ACON): A Breakthrough Partnership

Published

5 days ago

on

May 31, 2023

By

Aclarion, Inc. (NASDAQ: ACON) shares rocketed 157% Tuesday morning after their commercialization agreement with the London Clinic.

Aclarion, Inc. (NASDAQ: ACON) shares rocketed 157% Tuesday morning after their commercialization agreement with the London Clinic. The London Clinic is UK’s most renowned independent, private hospital, established 1932 with their Spine Clinic being the first specialist spinal unit based in England back in 1997.

“With a focus on providing the very best healthcare outcomes, The London Clinic is an ideal customer for Aclarion as the company works to deliver the Nociscan solution to physicians and patients around the world,” said John Sutcliffe MD, Neurosurgeon and Founder of London Spine Clinic. “The engagement with Aclarion will allow London Spine Clinic to continue offering the high-quality care our patients have come to expect. Patients need a careful assessment, diagnosis, and understanding of the different treatment options. Aclarion’s innovative Nociscan solution will enable us to objectively assess biomarkers associated with low back pain and enhance the precision of each diagnosis.”

More on Nociscan Technology

Aclarion, Inc.’s Nociscan Technology is an innovative medical solution that aims to revolutionize the diagnosis of disc-related conditions. They leverage biomarkers and proprietary augmented intelligence algorithms to help physicians identify the location of chronic low back pain.

What’s exciting is its advantages over the current standard of care. It offers a non-invasive approach, ensuring patient comfort and safety. Given it’s non-invasive, that also means 0 pain with 0 radiation (typically associated with traditional discography). The best part is it can seamlessly integrate into standard lumbar MRI protocols, making it a convenient and efficient option for healthcare providers. 

To Discover the Inside Scoop on ACON, Subscribe to Microcapdaily.com Right Now by entering your Email in the box below.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

The procedure takes approximately 25-45 minutes, thoroughly evaluating spinal discs without compromising accuracy. Additionally, Nociscan technology offers significant cost savings, with a list price of $1,450, making it an affordable alternative to traditional discograms. Overall, Aclarion, Inc.’s technological advances represent a significant push forward in disc-related diagnostic techniques, prioritizing patient well-being, convenience, and affordability.

https://twitter.com/TigerLineTrades/status/1663527784143093762?s=20

Nociscan Study

They also recently completed a study that spanned two years and involved 78 patients at a single site. The success rate soared to an impressive 85% for patients whose treatment strategy aligned with the disks identified by Nociscan. This represented a remarkable 22% improvement over patients whose treatment strategy did not consider the insights provided by Nociscan.

Aclarion expressed confidence that the results of the trial demonstrate the potential of Nociscan to assist physicians in successfully treating DLBP. Dr. Matthew Gornet, orthopedic surgeon and lead author of the study, enthusiastically endorsed Nociscan, stating, “The two-year surgical outcomes of the clinical trial provide unequivocal evidence of its effectiveness, particularly with regards to the primary endpoint, the Oswestry Disability Index (ODI). I firmly believe that Nociscan has the potential to revolutionize the standard of care and accurately aid all physicians treating chronic low back pain.”

It is worth noting that although Nociscan was performed on all patients in the study, it was not part of the surgical decision-making process, as highlighted by the company.

Conclusion

The commercial agreement between Aclarion, Inc. and the prestigious London Clinic signifies a significant milestone for both parties, carrying the potential for global recognition, revenue growth, and scalability. By integrating Aclarion’s innovative Nociscan Technology, the London Clinic demonstrates its commitment to delivering cutting-edge healthcare to optimize patient well-being and enhance clinical outcomes. Furthermore, the partnership’s success holds the potential for scaling Nociscan Technology to other institutions and markets, propelling Aclarion, Inc. to become a global leader in non-invasive medical technologies while driving substantial revenue growth.

We will update you on ACON when more details emerge, so make sure you are subscribed to Microcapdaily to know what’s happening in the markets!

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: We have not been compensated for this article/video. MicroCap Daily is not an investment advisor; this article/video does not provide investment advice. Always do your research, make your own investment decisions, or consult with your nearest financial advisor. This article/video is not a solicitation or recommendation to buy, sell, or hold securities. This article/video is our opinion, is meant for informational and educational purposes only, and does not provide investment advice. Past performance is not indicative of future performance.

Image by PIRO from Pixabay

Continue Reading

Emerging Markets

Aemetis Inc. (NASDAQ: AMTX) Pioneers Renewable Fuel Market with EPA Approval

Published

2 weeks ago

on

May 21, 2023

By

Aemetis (NASDAQ: AMTX) shares surged 105% this week. The renewable natural gas and renewable fuels company received approval from the EPA.

Aemetis, Inc. (NASDAQ: AMTX) shares surged 105% this week. The renewable natural gas and renewable fuels company received approval from the U.S. EPA to generate renewable identification numbers (RINs) under the federal Renewable Fuel Standard. They have six dairy biogas digesters up and running, with a seventh one scheduled to start operating in June 2023.

Aemetis plans to generate multiple sources of revenue from its renewable natural gas. They will sell the gas to replace petroleum diesel in transportation, sell California Low Carbon Fuel Standard credits to fuel blenders who need to meet carbon reduction requirements in California, sell the RINs generated under the federal Renewable Fuel Standard, and benefit from production tax credits starting in 2025 under the Inflation Reduction Act.

They have completed constructing and operating six dairy digesters, a biogas pipeline spanning over 40 miles, a central facility to upgrade biogas to renewable natural gas, and a utility pipeline interconnection unit. The renewable natural gas is injected into the utility gas system and stored underground until Aemetis Biogas obtains carbon intensity (CI) pathway approvals from the California Air Resources Board (CARB) to sell credits under the California Low Carbon Fuel Standard.

They have already completed 90 days of renewable natural gas production and data collection required for the CARB approval process. While the final pathway is under review by CARB, Aemetis can use a temporary CI pathway with a value of -150, allowing them to start generating revenue in the third quarter of 2023.

To Discover the Inside Scoop on AMTX, Subscribe to Microcapdaily.com Right Now by entering your Email in the box below.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Andy Foster, the president of Aemetis Biogas Inc., expressed excitement about the approval of Aemetis Biogas for generating D3 RINs, as it marks a significant milestone towards generating full product revenue. He emphasized that the company’s investments since 2019 have directly reduced greenhouse gas pollution, improved air quality in Central Valley communities, and created jobs. Aemetis is committed to expanding their network of dairy digesters and producing more carbon-negative renewable natural gas to replace petroleum diesel.

The dairy digesters, pipeline project, and biogas-to-RNG facility funding includes grants from the California Department of Food and Agriculture and the California Energy Commission. Aemetis also closed a $25 million long-term financing deal with Greater Commercial Lending last fall, supported by a loan guarantee from the USDA. This project financing has a low fixed interest rate for the first five years and spans over 20 years.

Aemetis has plans to file applications for an additional $100 million of loans from the USDA’s REAP loan program. These funds will support the engineering, permitting, and construction of 31 more dairies. Each loan application will be limited to a maximum of $25 million and carry a 20-year repayment term.

https://twitter.com/Theweedfarmer/status/1658946668052504576?s=20

Where could Aemetis, Inc. (NASDAQ: AMTX) be in 5 years?

The company has an ambitious Five Year Plan to generate substantial revenue and reduce air and carbon pollution. The plan projects $2.0 billion in revenues, $496 million in net income, and $682 million in adjusted EBITDA by 2027, with strong compound annual growth rates. Aemetis aims to expand its operations by producing Renewable Natural Gas (RNG), Sustainable Aviation Fuel (SAF), Renewable Diesel fuel (RD), and other low-carbon products. The plan emphasizes the positive financial impact of the Inflation Reduction Act.

The plan highlights the financial benefits of the Inflation Reduction Act, which enables the transfer of tax credits and incentives related to production, projected to improve net income by $341 million in 2027.

The plan also focuses on revenue growth in all product lines, including expanding the dairy RNG business, constructing a renewable jet/diesel plant, implementing carbon sequestration, and improving energy efficiencies. 

The company has already achieved significant milestones, such as completing biogas pipeline construction, upgrading facilities for biogas-to-RNG production, and progressing in carbon sequestration and renewable jet/diesel plant development. The company has also secured a biodiesel purchase agreement in India and made strides in constructing a solar microgrid and implementing energy-efficient measures.

We will update you on AMTX when more details emerge, so make sure you are subscribed to Microcapdaily to know what’s happening in the markets!

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: We have not been compensated for this article/video. MicroCap Daily is not an investment advisor; this article/video does not provide investment advice. Always do your research, make your own investment decisions, or consult with your nearest financial advisor. This article/video is not a solicitation or recommendation to buy, sell, or hold securities. This article/video is our opinion, is meant for informational and educational purposes only, and does not provide investment advice. Past performance is not indicative of future performance.

Image by Leopold Böttcher from Pixabay

Continue Reading

Emerging Markets

GSI Technology, Inc. (NASDAQ: GSIT): Pure AI Play Transforming Semiconductor Memory Solutions for Efficient AI Processing

Published

3 weeks ago

on

May 14, 2023

By

GSI Technology, Inc. (NASDAQ: GSIT) has witnessed a significant surge in its stock price, from $1.62 to $3.84, at the time of writing on Friday, May 12.

GSI Technology, Inc. (NASDAQ: GSIT) has witnessed a significant surge in its stock price, from $1.62 to $3.84, at the time of writing on Friday, May 12. This represents an impressive 137% increase; the volume has been off the hook. If you look at their historical chart, $GSIT had meager volume, sometimes as low as 300 shares traded in a day. If you do the math, that’s less than $500 worth of shares traded in a day – safe to say it was virtually illiquid.

So what happened, and what drove the stock to trade 50M shares with filings or news releases?

After an in-depth examination, GSI Technology, Inc. appears to have experienced a notable turning point in its market trajectory. The catalyst for this transformation was the company’s prominent feature on Fox News, triggering an exponential dissemination of information across various platforms. It is worth highlighting an intriguing phenomenon that tends to transpire in such circumstances: purchasing shares often induces a ripple effect, encouraging further buying activity.

With Fox News bringing the company into the spotlight and stimulating investor interest, a domino effect occurred among astute day traders who eagerly seized the opportunity to partake in this promising venture. Consequently, the trading volume for GSI Technology, Inc. skyrocketed to unprecedented levels, surpassing all previously recorded thresholds.

This surge in volume stands as a testament to the immense enthusiasm that enveloped the market as traders recognized the tremendous potential inherent in $GSIT. This collective enthusiasm resulted in an extraordinary demonstration of market engagement, reflecting a widespread acknowledgment of the company’s significance and the opportunities it presents.

https://twitter.com/SamanthaLaDuc/status/1657033207412293634?s=20

This development showcases the power of influential media coverage and underscores the intriguing dynamics that can arise when investor sentiment aligns with a compelling market narrative.

To Discover the Inside Scoop on GSIT, Subscribe to Microcapdaily.com Right Now by entering your Email in the box below.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Founded in 1995, GSI Technology Inc. has established itself as a prominent provider of semiconductor memory solutions. The company is focused on introducing new products that capitalize on its core strengths, which include radiation-hardened memory products for extreme environments and Gemini, an advanced processing unit (APU) designed to enhance performance in various artificial intelligence (AI) applications. Headquartered in Sunnyvale, California, GSI Technology operates sales offices in the Americas, Europe, and Asia.

GSI Technology is on the verge of reporting its earnings next week, and the company operates in the storage business, which supports the development of highly efficient AI chips. Traditionally, computing involves separate chips for storage and computation, necessitating frequent data exchange. This process incurs significant power consumption and presents scalability challenges.

To address these limitations, GSI Technology has developed a groundbreaking solution called In-memory processing. This innovation substantially reduces computation time from minutes to seconds, milliseconds, or even microseconds. Notably, it also significantly diminishes power consumption and overall cost of ownership. The key to this improvement lies in the massive parallel data processing offered by GSI’s technology, featuring two million-bit processors per chip compared to thousands found in standard graphic processing units (GPUs). Consequently, the system becomes more scalable, enabling efficient and accelerated AI processing.

By streamlining the computing process and integrating storage and computation on a single chip, GSI Technology aims to revolutionize AI processing. This approach offers notable benefits regarding power efficiency, computational speed, and scalability, making it an attractive solution for a wide range of AI applications.

In conclusion, GSI Technology, Inc. is poised to deliver innovative semiconductor memory solutions emphasizing AI chip development. The company aims to reduce computation time, power consumption, and total ownership cost through its In-memory processing technology while significantly improving scalability. With its upcoming earnings report, investors and industry observers will closely watch the company’s progress in the storage business and AI chip development.

We will update you on GSIT when more details emerge, so make sure you are subscribed to Microcapdaily to know what’s happening with GSIT.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: We have not been compensated for this article/video. MicroCap Daily is not an investment advisor; this article/video does not provide investment advice. Always do your research, make your own investment decisions, or consult with your nearest financial advisor. This article/video is not a solicitation or recommendation to buy, sell, or hold securities. This article/video is our opinion, is meant for informational and educational purposes only, and does not provide investment advice. Past performance is not indicative of future performance.

Image by Gerd Altmann from Pixabay

Continue Reading

Trending

© All rights reserved.

Sign up now for our 100% FREE Penny Stock Newsletter

Privacy Policy. we will never share your email with anyone.